- Report
- September 2023
- 180 Pages
Global
From €5342EUR$5,500USD£4,608GBP
- Report
- February 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- March 2024
- 139 Pages
Global
From €2913EUR$2,999USD£2,513GBP
- Report
- October 2023
- 181 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Drug Pipelines
- February 2024
- 80 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Clinical Trials
- April 2024
- 240 Pages
Global
From €2914EUR$3,000USD£2,514GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Drug Pipelines
- April 2024
- 230 Pages
Global
From €2914EUR$3,000USD£2,514GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- April 2024
- 75 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- April 2024
- 100 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1457EUR$1,500USD£1,257GBP
The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain.
The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more